Inventor · disambiguated record
Silvere M. Van Der Maarel
Also filed as: VAN DER MAAREL SILVERE M · VAN DER MAAREL SILVERE MARIA · VAN DER MAAREL SILVÈRE M · VAN DER MAAREL SILVÈRE MARIA
2 granted patents·8 pending applications·34 citations·filing 2006–2022
61Inventor score
Files withACADEMISCH ZIEKENHUIS LEIDEN4HUTCHINSON FRED CANCER RES2ARGENX IIP BV1BURDEN STEVEN J1VAN DER MAAREL SILVERE M1
Top patents by PatentIndex Score
10 records- 0185US10865445B2Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FLVAN DER MAAREL SILVERE M·Filed 2011·Granted Dec 15, 2020·29 cites·5 claims
- 0274US9574015B2Methods for treating muscle specific receptor kinase (MuSK) myasthenia gravis with the Ig1 domain of MuSKBURDEN STEVEN J·Filed 2014·Granted Feb 21, 2017·5 cites·11 claims
- 0359US2021198739A1Methods for determining the presence or risk of developing facioscapulohumeral dystrophy (fshd)HUTCHINSON FRED CANCER RES·Filed 2020·Application pending·0 cites
- 0451US2023110188A1MuSK AGONIST ANTIBODYARGENX IIP BV·Filed 2022·Application pending·0 cites
- 0551US2012270930A1Methods and compositions for dysferlin exon-skippingVAN DER MAAREL SILVERE MARIA·Filed 2009·Application pending·0 cites
- 0642US2015159216A1Methods and compositions related to the smchd1 geneHUTCHINSON FRED CANCER RES·Filed 2013·Application pending·0 cites
- 0740US2010323905A1Vhh for the Diagnosis, Prevention and Treatment of Diseases Associated with Protein AggregatesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2006·Application pending·0 cites
- 0839US2018147256A1Means and methods for treating facioscapulohumeral muscular dystrophy (fshd).ACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Application pending·0 cites
- 0938US2022002438A1Musk inhibitionACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Application pending·0 cites
- 1038US2024043562A1Musk activationACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Silvere M. Van Der Maarel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →